Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FP74Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,621
Award facts
- Contract value 100% obligated
- $16,621.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a firm fixed price ceiling value of $16,621.46 and an ultimate completion date of September 15, 2025. This delivery order was issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The contract was non-set-aside and awarded through open competition, consistent with AmerisourceBergen's standard federal procurement approach.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The SPE2DX IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. Dupixent (dupilumab) is a specialty pharmaceutical indicated for treating conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis, reflecting the breadth of therapeutic medications AmerisourceBergen delivers through its federal contracts.
Quick answers
Who was awarded contract SPE2DB25FP74Q?
SPE2DB25FP74Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FP74Q worth?
The government has obligated $16,621 on SPE2DB25FP74Q.
Is contract SPE2DB25FP74Q an order under another contract?
Yes. SPE2DB25FP74Q is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP74Q competed?
The extent of competition for SPE2DB25FP74Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award